Troglitazone-induced liver failure: a case study
- 1 March 2003
- journal article
- case report
- Published by Elsevier in The American Journal of Medicine
- Vol. 114 (4) , 299-306
- https://doi.org/10.1016/s0002-9343(02)01529-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: A case report with autopsy examinationHuman Pathology, 2000
- Troglitazone-Associated Hepatic FailureAmerican Journal of Gastroenterology, 2000
- Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug AdministrationAmerican Journal of Gastroenterology, 2000
- CASE REPORT: Troglitazone-Induced Fulminant Hepatic FailureDigestive Diseases and Sciences, 2000
- Severe Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1999
- Fatal Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1998
- An Autopsy Case of Troglitazone-Induced Fulminant HepatitisDiabetes Care, 1998
- Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with TroglitazoneAnnals of Internal Medicine, 1998
- Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case ReportAnnals of Internal Medicine, 1998
- A Novel Antidiabetic Drug, Troglitazone — Reason for Hope and ConcernNew England Journal of Medicine, 1998